Prophylactic Drugs for Malaria: Why Do We Need Another One?

Journal of Travel Medicine

Volumn 6, Issue , 1999, Pages S2-S6

  Kain, Kevin C ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; BISMUTH SALICYLATE; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; MINOCYCLINE; PRIMAQUINE; PROGUANIL; TAFENOQUINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; APHTHOUS ULCER; AUTOIMMUNE HEPATITIS; CONVULSION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGUS ULCER; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION RISK; INSOMNIA; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MEDICAL DECISION MAKING; ORAL DRUG ADMINISTRATION; PRURITUS; PSYCHOSIS; REVIEW; SCORING SYSTEM; SERUM SICKNESS; TRAVEL; VERTIGO;

ADULT; ANTIMALARIALS; ATOVAQUONE; CHEMOPREVENTION; CHILD; CHLOROQUINE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG COMBINATIONS; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALARIA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PROGUANIL; RISK FACTORS; TRAVEL; TRAVEL MEDICINE; YOUNG ADULT;

EID: 0032969392     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1093/jtm/6.suppl.S2     Document Type: Article

References (55)

1. WHO Weekly Epidemiological Record. 71. 1996.
2. WHO. International Travel and Health. Vaccination requirements & health advice 1997. Geneva: WHO. 1997.
3. Miller L. The challenge of malaria. Science 1994; 257:36-37.
4. Heppner DG. Ballou WR. Malaria in 1999: advances in diagnosis, drugs and vaccine development. Curr Opin Infect Dis 1999 (in press).
5. Kain KC. Chemotherapy of drug-resistant malaria. Can J Infect Dis 1996:7:25-33.
6. Bouma MJ, Sondorp HE, van der Kaaj Hf. Health and climate change. Lancet 1994: 343:302.
7. Loevinsohn ME. Climatic warming and increased malaria incidence in Rwanda. Lancet 1994: 343:714-718.
8. Bouma MJ. Sondorp HE, van der Kaaj HJ. Climate change and periodic epidemic malaria. Lancet 1994: 343:1440.
9. Handszuh H, Water: SR. Travel and tourism trends. In: Dupont HL, Steffcn R. eds. Textbook of travel medicine and health. Hamilton, ON:BC Decker, 1997:37.
10. Molyncux M, Fox R. Diagnosis and treatment of malaria in Britain. BMJ 1993:306:1175-1180.
11. Freedman DO. Imported malaria-here to stay. Am J Med 1992: 93:239-242.
12. Hoffman SL. Diagnosis, treatment and prevention of malaria. Med Clin North Am 1992:76:1327-1355.
13. Bradley J, Warhurst DC. Blaze M. et al. Malaria imported into the United Kingdom in 1996. Eurosurveillance 1998:3:40-42.
14. Kain KC. Keystone JS. Malaria in travelers. Med Clin North Am 1998; 12:267-284.
15. Laboratory Center for Disease Control. Notifiable Diseases Annual Summary-1994.Can Commun Dis Rep 1996;22 (Suppl 2):74-75.
16. Laekritz EM, Lobel HO. Howell J. et al. Imported Plasmodium falciparum malaria in American travelers to Africa. JAMA 1991; 265:383-385.
17. Kain KC. Harrington MA. Tennyson S. Kevstone IS. Imported malaria: prospective analysis ot problems in diagnosis and management. Clin Infect Dis 1998;27:142-149.
18. Fronde JRL. Weiss LM. Tanowitz HB. et al. Imported malaria in the Bronx: review of 51 cases recorded from 1986 to 1991. Clin Infect Dis 1992; 15:774-780.
19. Greenbcrg A, Lobel HO. Mortality from Plasmodium falciparum malaria in travelers from the United States. Ann Intern Med 1990; 113:326-327.
20. Winters RA. Murray HW Malaria-the mime revisited: fifteen more years of experience at a New York City teaching hospital. Am JJ Med 1992:93:243-246.
21. Humar A, Sharma S, Zoutman D, Kain KC. Fatal falciparum malaria in Canadian travelers. Can Med Assoc J 1997: 156:1165-1167.
22. Behrens RH, Curtis CF. Malaria in travelers: epidemiology and prevention. Br Med Bull 1993;49:363-381.
23. Phillips RE, Solomon T Cerebral malaria in children. Lancet 1990; 336:1355.
24. Campbell CC. Challenges facing antimalarial therapy in Africa. J Infect Dis 1991; 163:1207-1211.
25. Centers for Disease Control and Prevention. Summary of notifiable diseases. MM WR 1 997; 46:SS-2.
26. Quach C. Kain KC, MacPherson DW, et al. Malaria deaths in Canadian travelers. Can Commun Dis Rep 1999 (in press).
27. Health information for international travel-1996-1997. Atlanta, GA: Department of Health and Human Services. 1997.
28. Canadian recommendations for the prevention and treatment of malaria among international travelers. Can Commun Dis Rep 1997: 23 (Suppl 5): 1-18.
29. Shanks GD. Kremsner PG. Sukwa TY. et al. Atovaquone and proguaml hydrochloride for prophylaxis of malaria. J Travel Med 1999; 6(Suppl 1):S21-S27.
30. Shanks GD. Possible options for malaria chemoprophylaxis on the horizon. J Travel Med 1999:6(Suppl 1):S31-S32.
31. Ohrt C, Richie TL. Widjaja H, et al. Mefloquine compared with doxy-cycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997; 126:963-972.
32. Stetfen R, Fuchs E. Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993;341:1299-1303.
33. Hill DR. Behrens RH. Bradley DJ. The risk of malaria in travelers to Thailand. Trans R Soc Trop Med Hyg 1996; 90: 680-681.
34. Murphy G, Basri H. Purnomo. et al. Vivax malaria resistant treatment and prophylaxis with chloroquine. Lancet 1993; 341:96-100.
35. Phillips E|. Keystone JS, Kam KC. Failure of combined chloroquine and high dose primaquine therapy tor Plasmodium vivax acquired in Guyana. South America. Clin Infect Dis 1996: 23:1171-1173.
36. Lobel HO. Phillips-Howard PA. Brandling-Bennett AD, et al. Malaria incidence and prevention among European and North American travelers to Kern a. Bull World Health Organ 1990;68:209-215.
37. Lobel HO. Muni M. Eng T. et al. Long term malaria prophylaxis with weekly mefloquine. Lancet 1993;341 :848-851.
38. Bradley DJ. Warhurst DC. Guidelines tor the prevention ot malaria in travelers from the United Kingdom. Cominun Dis Rev 1997; 7:R137-R152.
39. Schlagenhauf P. Mefloquine, methodologies, and the media, J Travel Med 1996;3:197-199.
40. Lobel HO. Kozarskv PE. Update on prevention of malaria tor travelers. JAMA 1997;278:1767-1771.
41. Crott A. Garner P. Mefloquine to prevent malaria: a systematic review of trials. BMJ 1997: 315:1412-1416.
42. MacPherson D, Gamble K, Tessier D, et al. Mefloquine tolerance: randomized double-blind placebo controlled study [abstract]. 5th Meeting ot the International Society tor Travel Medicine. Geneva. 1997.
43. Weinke T. Trautmann M, Held T. et al. "Neuropsychiatric side effects after the use of mefloquine. Am T Trop Med Hyg 1991;45:86-91.
44. White NJ. Mefloquine. BMJ 1994: 308:286-287.
45. Barrett PD. Emmins PJ. Clarke PD, et al. Comparison ot adverse events associated with use ot mefloquine and combination ot chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers. BMJ 1996: 313:525-528.
46. Boudreau E. Schuster B. Sanchez J. et al. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 1993; 44:257-265.
47. Davis TME. Dembo LG, Kaye-Eddie SA. et al. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial. Br J Clin Pharmacol 1996: 42:415-421.
48. Wallace MR. Sharp T W. Smoak B. et al. Malaria among United States troops in Somalia. Am J Med 1996; 100:49-55.
49. Lochary ME. Lockhart PB. Williams WT. Doxyeyclme and staining of permanent teeth. Pediatr Infect DisJ 1998; 17:429-430.
50. Cough A. Chapman S. Wagstaff K. Emery P, Elias E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996; 312:169-172.
51. Gottlieb A. Safety ot nunoevcline for acne. Lancet 1997; 349:374.
52. Phillips-Howard PA. Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 1996; 14:131-145.
53. Nosten F. ter Kuile F. Maelankiri L. et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994; 169:595-603.
54. Vanhauwere B, Maradit H. Kerr L. Post-marketing surveillance of prophylactic mefloquine use in pregnancy. Am J Trop Med Hyg 1998; 58:17-21.
55. Smoak BL. Writer JV. Keep LW. et al. The effects of inadvertent exposure to mefloquine chemoprophylaxis on pregnancy outcomes and infants ot US Army servicewomen. J Infect Dis 1997: 176:831-833.